There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

The study was published online in JAMA Neurology on March 31, 2025.

Atrial fibrillation (AF) is the most common cardiac arrhythmia and predisposes patients to stroke and systemic embolism. Vitamin K antagonists have been the only available oral anticoagulants for ...

A study led by researchers at the Duke Clinical Research Institute found that just 46 of atrial fibrillation inpatients received a blood thinner at discharge. Disclaimer: AAAS and EurekAlert!

Dr. Ratika Parkash, MD, FRCPC, Cardiologist, discusses how stroke prevention with anticoagulant treatment is important in ...

A lower apixaban dose is indicated in patients with an eGFR less than 30 mL/min/1.73 m2, regardless of dialysis status.

"In these OAC-naive patients, asundexian was associated with a slight increase in stroke rates but demonstrated a lower risk ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant ...

Recent study results suggest that atrial fibrillation increases the risk of dementia and that the risk association is stronger for younger individuals.

One of AI’s most immediate impacts is in screening and identifying patients who may have asymptomatic or paroxysmal AF, those ...

Stroke is a leading cause of disability and death worldwide, yet 80% of strokes are preventable with proper lifestyle ...